253 related articles for article (PubMed ID: 30083255)
21. Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway.
Li S; Xu X; Jiang M; Bi Y; Xu J; Han M
Mol Med Rep; 2015 Jun; 11(6):4454-62. PubMed ID: 25625500
[TBL] [Abstract][Full Text] [Related]
22. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S
Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629
[TBL] [Abstract][Full Text] [Related]
23. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
Majumder M; Landman E; Liu L; Hess D; Lala PK
Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
[TBL] [Abstract][Full Text] [Related]
25. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
26. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
[TBL] [Abstract][Full Text] [Related]
27. Fluid shear stress induces cancer stem cell-like phenotype in MCF7 breast cancer cell line without inducing epithelial to mesenchymal transition.
Triantafillu UL; Park S; Klaassen NL; Raddatz AD; Kim Y
Int J Oncol; 2017 Mar; 50(3):993-1001. PubMed ID: 28197635
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of invasion and experimental metastasis of murine melanoma cells by Ipomoea obscura (L.) is mediated through the down-regulation of inflammatory mediators and matrix-metalloproteinases.
Hamsa TP; Kuttan G
J Exp Ther Oncol; 2011; 9(2):139-51. PubMed ID: 21699021
[TBL] [Abstract][Full Text] [Related]
29. CTC clusters induced by heparanase enhance breast cancer metastasis.
Wei RR; Sun DN; Yang H; Yan J; Zhang X; Zheng XL; Fu XH; Geng MY; Huang X; Ding J
Acta Pharmacol Sin; 2018 Aug; 39(8):1326-1337. PubMed ID: 29417941
[TBL] [Abstract][Full Text] [Related]
30. COX-2 modulates mammary tumor progression in response to collagen density.
Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
[TBL] [Abstract][Full Text] [Related]
31. Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism.
Xu Y; Yang X; Wang T; Yang L; He YY; Miskimins K; Qian SY
BMC Cancer; 2018 Mar; 18(1):330. PubMed ID: 29587668
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
33. Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells.
Pinkas J; Martin SS; Leder P
Mol Cancer Res; 2004 Oct; 2(10):551-6. PubMed ID: 15498929
[TBL] [Abstract][Full Text] [Related]
34. Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis.
Ebright RY; Lee S; Wittner BS; Niederhoffer KL; Nicholson BT; Bardia A; Truesdell S; Wiley DF; Wesley B; Li S; Mai A; Aceto N; Vincent-Jordan N; Szabolcs A; Chirn B; Kreuzer J; Comaills V; Kalinich M; Haas W; Ting DT; Toner M; Vasudevan S; Haber DA; Maheswaran S; Micalizzi DS
Science; 2020 Mar; 367(6485):1468-1473. PubMed ID: 32029688
[TBL] [Abstract][Full Text] [Related]
35. Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures.
Nakano T; Kanai Y; Amano Y; Yoshimoto T; Matsubara D; Shibano T; Tamura T; Oguni S; Katashiba S; Ito T; Murakami Y; Fukayama M; Murakami T; Endo S; Niki T
PLoS One; 2017; 12(8):e0181342. PubMed ID: 28786996
[TBL] [Abstract][Full Text] [Related]
36. NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2.
Yiu GK; Toker A
J Biol Chem; 2006 May; 281(18):12210-7. PubMed ID: 16505480
[TBL] [Abstract][Full Text] [Related]
37. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.
Kundu N; Fulton AM
Cancer Res; 2002 Apr; 62(8):2343-6. PubMed ID: 11956094
[TBL] [Abstract][Full Text] [Related]
38. COX-2 induces IL-11 production in human breast cancer cells.
Singh B; Berry JA; Shoher A; Lucci A
J Surg Res; 2006 Apr; 131(2):267-75. PubMed ID: 16457848
[TBL] [Abstract][Full Text] [Related]
39. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]